drugset / Trial / NCT00837941

A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)

NCT00837941

Phase 2 Withdrawn Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine if analgesic efficacy can be detected with single dose administration in patients with chronic neuropathic pain due to painful diabetic neuropathy.

Timeline

Start
2009-04
Primary completion
2009-08
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Diphenhydramine Unknown 25 mg
Subject Duloxetine Small molecule 60 mg
Subject Pregabalin Small molecule 300 mg